Capital Flow Monitor · Sponsors · CIK 1604801

Armis Biopharma, Inc.

2401 RESEARCH BLVD, SUITE 205, FORT COLLINS, CO, 80526 · 970-295-4373

Other Health Care · Corporation· inc. DELAWARE true

Fit score

Offering

$3.0M

Sold

$1.0M

% sold

33.3%

Investors

1

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2025-07-10 D ·current 506(b) $3.0M $1.0M 33.3% 1 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed.

  • Theodore Ziemann — Director, Fort Collins, CO
  • Steve Coder — Executive Officer / Director, Fort Collins, CO
  • Alan Ruud — Director, Fort Collins, CO
  • Alan Smith, Ph.D. — Director, Fort Collins, CO
  • Christopher Rudd — Director, Fort Collins, CO
  • Michael Voss — Executive Officer / Director, Fort Collins, CO
  • Michael Litwack — Director, Fort Collins, CO
  • William Nelson, MD, Ph.D. — Director, Fort Collins, CO

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.